BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2447 related articles for article (PubMed ID: 29940584)

  • 1. Effects of the TLR4/Myd88/NF-κB Signaling Pathway on NLRP3 Inflammasome in Coronary Microembolization-Induced Myocardial Injury.
    Su Q; Li L; Sun Y; Yang H; Ye Z; Zhao J
    Cell Physiol Biochem; 2018; 47(4):1497-1508. PubMed ID: 29940584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of TLR4/MyD88/NF-κB signaling pathway in coronary microembolization-induced myocardial injury prevented and treated with nicorandil.
    Su Q; Lv X; Sun Y; Ye Z; Kong B; Qin Z
    Biomed Pharmacother; 2018 Oct; 106():776-784. PubMed ID: 29990871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TAK-242 Protects Against Apoptosis in Coronary Microembolization-Induced Myocardial Injury in Rats by Suppressing TLR4/NF-κB Signaling Pathway.
    Wang XT; Lu YX; Sun YH; He WK; Liang JB; Li L
    Cell Physiol Biochem; 2017; 41(4):1675-1683. PubMed ID: 28359050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypoxia-inducible factor-1α attenuates myocardial inflammatory injury in rats induced by coronary microembolization.
    Chen QF; Wang W; Huang Z; Huang DL
    An Acad Bras Cienc; 2020; 92(1):e20190658. PubMed ID: 32428089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The protective effect of Luteolin on myocardial ischemia/reperfusion (I/R) injury through TLR4/NF-κB/NLRP3 inflammasome pathway.
    Zhang X; Du Q; Yang Y; Wang J; Dou S; Liu C; Duan J
    Biomed Pharmacother; 2017 Jul; 91():1042-1052. PubMed ID: 28525945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atorvastatin suppresses NLRP3 inflammasome activation via TLR4/MyD88/NF-κB signaling in PMA-stimulated THP-1 monocytes.
    Kong F; Ye B; Lin L; Cai X; Huang W; Huang Z
    Biomed Pharmacother; 2016 Aug; 82():167-72. PubMed ID: 27470352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective effects and mechanism of curcumin on myocardial injury induced by coronary microembolization.
    Liu Y; Liu Y; Huang X; Zhang J; Yang L
    J Cell Biochem; 2019 Apr; 120(4):5695-5703. PubMed ID: 30324684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resveratrol pretreatment alleviates NLRP3 inflammasome-mediated cardiomyocyte pyroptosis by targeting TLR4/MyD88/NF-κB signaling cascade in coronary microembolization-induced myocardial damage.
    Luo CJ; Li T; Li HL; Zhou Y; Li L
    Korean J Physiol Pharmacol; 2023 Mar; 27(2):143-155. PubMed ID: 36815254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydrogen-Rich Saline Attenuated Subarachnoid Hemorrhage-Induced Early Brain Injury in Rats by Suppressing Inflammatory Response: Possible Involvement of NF-κB Pathway and NLRP3 Inflammasome.
    Shao A; Wu H; Hong Y; Tu S; Sun X; Wu Q; Zhao Q; Zhang J; Sheng J
    Mol Neurobiol; 2016 Jul; 53(5):3462-3476. PubMed ID: 26091790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nicorandil inhibits TLR4/MyD88/NF-κB/NLRP3 signaling pathway to reduce pyroptosis in rats with myocardial infarction.
    Chen F; Chen ZQ; Zhong GL; Zhu JJ
    Exp Biol Med (Maywood); 2021 Sep; 246(17):1938-1947. PubMed ID: 34034564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of high mobility group A1/nuclear factor-kappa B signaling in coronary microembolization-induced myocardial injury.
    Su Q; Lv X; Sun Y; Yang H; Ye Z; Li L
    Biomed Pharmacother; 2018 Sep; 105():1164-1171. PubMed ID: 30021353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MUC1 attenuates neutrophilic airway inflammation in asthma by reducing NLRP3 inflammasome-mediated pyroptosis through the inhibition of the TLR4/MyD88/NF-κB pathway.
    Liu L; Zhou L; Wang L; Mao Z; Zheng P; Zhang F; Zhang H; Liu H
    Respir Res; 2023 Oct; 24(1):255. PubMed ID: 37880668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tanshinone IIA reduces pyroptosis in rats with coronary microembolization by inhibiting the TLR4/MyD88/NF-κB/NLRP3 pathway.
    Li HL; Li T; Chen ZQ; Li L
    Korean J Physiol Pharmacol; 2022 Sep; 26(5):335-345. PubMed ID: 36039734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Berberine on Activation of TLR4-NFκB Signaling Pathway and NLRP3 Inflammasome in Patients with Gout.
    Dang WT; Xu D; Zhou JG
    Chin J Integr Med; 2023 Jan; 29(1):10-18. PubMed ID: 36125615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Artesunate ameliorates high glucose-induced rat glomerular mesangial cell injury by suppressing the TLR4/NF-κB/NLRP3 inflammasome pathway.
    Sun Z; Ma Y; Chen F; Wang S; Chen B; Shi J
    Chem Biol Interact; 2018 Sep; 293():11-19. PubMed ID: 30031708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Baicalein ameliorates TNBS-induced colitis by suppressing TLR4/MyD88 signaling cascade and NLRP3 inflammasome activation in mice.
    Luo X; Yu Z; Deng C; Zhang J; Ren G; Sun A; Mani S; Wang Z; Dou W
    Sci Rep; 2017 Nov; 7(1):16374. PubMed ID: 29180692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MD-2 regulates LPS-induced NLRP3 inflammasome activation and IL-1beta secretion by a MyD88/NF-κB-dependent pathway in alveolar macrophages cell line.
    Luo M; Hu L; Li D; Wang Y; He Y; Zhu L; Ren W
    Mol Immunol; 2017 Oct; 90():1-10. PubMed ID: 28654770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LuQi Formula Ameliorates Myocardial Fibrosis by Suppressing TLR4/MyD88/NF-
    Zhang X; Qu H; Yang T; Liu Q; Zhao D; Liu W; Wang T; Zhou H
    Evid Based Complement Alternat Med; 2022; 2022():5867987. PubMed ID: 35310035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NACHT, LRR and PYD domains-containing protein 3 inflammasome is activated and inhibited by berberine via toll-like receptor 4/myeloid differentiation primary response gene 88/nuclear factor-κB pathway, in phorbol 12-myristate 13-acetate-induced macrophages.
    Huang Z; Ye B; Han J; Kong F; Shan P; Lu Z; Huang Z; Huang W
    Mol Med Rep; 2018 Feb; 17(2):2673-2680. PubMed ID: 29207123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. M2 macrophage-derived exosomes carry microRNA-148a to alleviate myocardial ischemia/reperfusion injury via inhibiting TXNIP and the TLR4/NF-κB/NLRP3 inflammasome signaling pathway.
    Dai Y; Wang S; Chang S; Ren D; Shali S; Li C; Yang H; Huang Z; Ge J
    J Mol Cell Cardiol; 2020 May; 142():65-79. PubMed ID: 32087217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 123.